YAP1 and coronary atherosclerosis measurement: The small-molecule drug hesperidin can target YAP to achieve pharmacological effect of inhibiting neointima formation, which provides potential clinical application for more natural drugs to inhibit neointima formation of blood vessels with small molecules, and provides a new idea for the treatment of carotid artery stenosis from the perspective of regulating LLPS.